Page 143 - CW E-Magazine (27-8-2024)
P. 143

Pharmaceuticals


       GOOD-DISTRIBUTION PRACTICES
       DCGI introduces new traceability rules to address

       fake medicines issue


          India’s leading drug regulator, the  seamlessly could prove vital in identify-  practices into the Drugs and Cosmetic
       Drugs Controller General of India  ing the exact point in the supply chain  Rules, 1945, as a formal Schedule. The
       (DCGI), has established standard opera-  where adulteration occurred or where  discussion highlighted that due to the
       ting procedures and guidelines aimed  counterfeit drugs were introduced.  non-mandatory nature of existing guide-
       at enhancing product traceability across                           lines, there has been a lack of assurance
       the supply chain. This move comes in   This initiative gains importance  regarding the maintenance of proper
       response to the increasing threat posed  as the Indian pharmaceutical sector  drug storage conditions during transit to
       by counterfeit and substandard medicines.  has come under international scrutiny  wholesale and retail levels by manufac-
                                         following accusations linking fake  turers.
          These new good-distribution practices  cough syrups produced in India  to the
       have  been  formulated  by  the  DCGI  to  deaths of children in Gambia, Cameroon,   The draft guidelines on good distri-
       address the critical challenge of ensur-  and Uzbekistan.          bution practices have been aligned with
       ing product traceability, which has been                           World Health Organization standards,
       hindered by insuffi cient documentation   During the DCGI’s drugs consulta-  and stakeholders have been given 30
       throughout the distribution network, the  tive committee meeting in June, it was  days to provide their feedback and sug-
       report said. The ability to trace products  resolved to integrate good distribution  gestions before these rules are fi nalised.

       SUSTAINABILITY CRITERIA
       Syngene secures silver rating in EcoVadis sustainability

       index

          Syngene International – a global con-  refl ects the broad commitment we make  tions for clients while respecting the planet
       tract research, development and manu-  every day to run our business in a respon-  and the needs of our communities today
       facturing organization (CRDMO) – has  sible and sustainable way.  The award  and for generations to come,” commented
       achieved the prestigious silver rating in the  refl ects the substantial progress we have  Mr. Jonathan Hunt, Managing Direc-
       EcoVadis  sustainability  index,  refl ecting  made in reducing our environmental foot-  tor and CEO, Syngene. The silver rating
       its commitment to excellence in Environ-  print as well as our strong commitment to  refl ects the company’s efforts on all four
       mental, Social, and Governance (ESG)  good corporate governance.   dimensions: 82% renewable energy across
       practices. This places the company among                           all campuses; 96% of waste recycled; 45%
       the top 15% of companies assessed world-  We are committed to continuing our  water recycled or reused; and 70% of total
       wide in the past year.            efforts, using our scientifi c expertise and  procurement is from domestic suppliers
                                         new technology to provide scientifi c solu-  in India.
          EcoVadis, recognised as a trusted pro-
       vider of business sustainability ratings,  USFDA issues warning letter to
       evaluates companies against 21 sustain-  Aurobindo arm
       ability criteria under four core themes:
       Environment, Labor & Human Rights,   A formulation manufacturing faci-  from the USFDA. “Subsequent to OAI,
       Ethics, and Sustainable Procurement.  lity  of Eugia Pharma Specialities, a  the  unit  has received  a  warning  letter.
       Over 100,000 companies are assessed  wholly  owned subsidiary of Aurobindo  There is no impact on the existing sup-
       by  EcoVadis  every  year and  the  rating  Pharma, received a warning letter from  plies to the US markets. The company
       to  Syngene was awarded following a  the  US  Food and Drug  Administration  remains committed to work closely with
       rigorous evaluation.              (USFDA). The Hyderabad-based Auro-  the USFDA and continues to enhance
                                         bindo, earlier said, the unit III received  its compliance on an ongoing basis,” it
          “Achieving the EcoVadis silver rating  Offi cial  Action  Indicated  (OAI)  status  informed the stock exchange.


       Chemical Weekly  August 27, 2024                                                                143


                                      Contents    Index to Advertisers    Index to Products Advertised
   138   139   140   141   142   143   144   145   146   147   148